[29-52-pm1] Clinical Pharmacy 27, Pharmacotherapies (Cancer)

[29-52-pm1-03S] Biomarker for atezolizumab/ bevacizumab combination and lenvatinib therapy in patients with HCC

○Yuina Koike¹, Yuka Kyoso¹, Kunihide Mori^2,3, Yasuaki Tatsumi¹, Hidenari Nagai^2,3, Koji Higai¹ (1. Sch. Pharm. Sci.,Toho Univ., 2. Dept. of Internal Medicine (Omori), Toho Univ., 3. Div. of Gastroenterology and Hepat., Tokyo Kamata Medical Center)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.